Wolters Kluwer Named 2021 North America Company of the Year for Clinical Decision Support

Rhea-AI Summary

Wolters Kluwer Health, a leader in clinical technology, received the 2021 North America Company of the Year Award from Frost & Sullivan for its comprehensive clinical decision support (CDS) solutions. The award recognizes Wolters Kluwer's ability to enhance clinical decision-making, reduce diagnostic errors, and streamline workflows during healthcare challenges, such as the COVID-19 pandemic. The company demonstrated its commitment to providing accurate evidence-based content, with its UpToDate platform accessed 31.1 million times by 1.3 million clinicians since February 2020.

Positive

• Recognition as Frost & Sullivan's 2021 North America Company of the Year enhances brand credibility and visibility.
• CDS solutions contribute to improved clinical decision-making, reducing diagnostic errors and workflow disruptions.
• Access to UpToDate's COVID-19 topics reached 31.1 million views from 1.3 million clinicians, showcasing strong engagement during a public health crisis.

Negative

• None.

UpToDate, Lexicomp, Emmi, Medi-Span, Sentri7 and POC Advisor solutions recognized by Frost & Sullivan as key enablers of informed decision-making at the point of care

WALTHAM, Mass.--(BUSINESS WIRE)-- Wolters Kluwer, Health, a leading global provider of trusted clinical technology and evidence-based solutions, is recognized by Frost & Sullivan with the 2021 North America Company of the Year Award. The honors follow Frost & Sullivan’s assessment of the North American clinical decision support (CDS) solutions market. The complete portfolio of Wolters Kluwer CDS solutions were highlighted for helping clinicians meaningfully improve clinical decision-making, reduce diagnostic errors, and prevent workflow disruptions.

“Our commitment has always been to empower clinicians and patients to make informed care decisions based on evidence-based content, and that requires delivering trusted information within their workflow,” said Greg Samios, President and CEO of Clinical Effectiveness, Wolters Kluwer, Health. “This recognition by Frost & Sullivan is a testament to our diligence in ensuring our solutions help align decision making across the continuum of care, helping to reduce care variability and improving outcomes.”

Aligned solutions and harmonized content

As care teams have expanded, clinical decisions are being made across a more significant number of roles, introducing the risk of misaligned decisions. When expanded care teams consistently use CDS solutions, clinicians can focus on fostering more aligned decision-making on behalf of their patients. That, in turn, can help to standardize care and improve outcomes.

Frost & Sullivan recognizes the Wolters Kluwer editorial team for its commitment to harmonizing content across its core CDS solutions. This coordination contributes to the availability of solutions that draw from the same evidence to help address the unique needs of clinicians and their patients along the entire care continuum. This supports the company's ability to deliver on a commitment to provide the best care everywhere.

“Wolters Kluwer’s multi-layer editorial policy involves continuous, systematic, and transparent review, identification, and synthesis of new clinical evidence,” said Azza Fazar, Best Practices Research, Frost and Sullivan. “The company’s highly skilled network of external physician editors and authors and in-house physician deputy editors comprehensively review medical literature, considering its quality, the hierarchy of evidence, and clinical relevance.”

Wolters Kluwer COVID-19 response

The COVID-19 pandemic exacerbated the strain on the healthcare industry with the increased pressure to recruit and retain physicians, who were quickly overwhelmed by the caseloads of patients presenting to their hospitals. As the pandemic worsened in the U.S., the volume and pace of clinical research about the novel virus made it impossible for clinicians to keep up with the latest literature.

Wolters Kluwer’s rigorous editorial model provides a framework for an immediate and dynamic response to crises such as the coronavirus pandemic, the West Africa Ebola outbreak, Haiti earthquakes and other natural disasters worldwide. UpToDate now has a total of 94 COVID-19 topics. Since February 2020, COVID-19 topics in UpToDate have been viewed 31.1 million times by 1.3 million individual clinicians. Wolters Kluwer continues to offer free access to COVID-19 topics, which clinicians can access on the Wolters Kluwer website.

About the award

Each year, Frost & Sullivan presents a Company of the Year award to the organization that demonstrates excellence in terms of growth strategy and implementation in its field. The award recognizes a high degree of innovation with products and technologies and the resulting leadership in customer value and market penetration.

Frost & Sullivan Best Practices awards recognize companies in various regional and global markets for demonstrating outstanding achievement and superior performance in leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analyses, and extensive secondary research to identify best practices in the industry.

To learn more, download the full Frost & Sullivan award report.

About Wolters Kluwer

Wolters Kluwer (WKL) is a global leader in professional information, software solutions, and services for the clinicians, nurses, accountants, lawyers, and tax, finance, audit, risk, compliance, and regulatory sectors. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with advanced technology and services.

Wolters Kluwer reported 2020 annual revenues of €4.6 billion. The group serves customers in over 180 countries, maintains operations in over 40 countries, and employs approximately 19,200 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands.

Wolters Kluwer provides trusted clinical technology and evidence-based solutions that engage clinicians, patients, researchers and students in effective decision-making and outcomes across healthcare. We support clinical effectiveness, learning and research, clinical surveillance, and compliance, as well as data solutions. For more information about our solutions, visit https://www.wolterskluwer.com/en/health and follow us on LinkedIn and Twitter @WKHealth.

For more information, visit www.wolterskluwer.com, follow us on Twitter, Facebook, LinkedIn, and YouTube.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220203005589/en/

Media

André Rebelo

Sr. Global Public Relations Manager

Wolters Kluwer Health

+1 (781) 392-2411

andre.rebelo@wolterskluwer.com

Source: Wolters Kluwer Health

FAQ

What recognition did Wolters Kluwer receive in 2021?

Wolters Kluwer was awarded the 2021 North America Company of the Year Award by Frost & Sullivan.

What are the benefits of Wolters Kluwer's CDS solutions?

The CDS solutions improve clinical decision-making and reduce diagnostic errors and workflow disruptions.

How many clinicians accessed COVID-19 topics in UpToDate?

Since February 2020, COVID-19 topics in UpToDate have been viewed 31.1 million times by 1.3 million individual clinicians.

What is the mission of Wolters Kluwer Health?

Wolters Kluwer Health aims to empower clinicians and patients to make informed care decisions based on evidence-based content.

How does Wolters Kluwer ensure accurate clinical information?

Wolters Kluwer follows a systematic editorial process involving external and in-house physician editors to review medical literature.